{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T15:40:48Z","timestamp":1775058048309,"version":"3.50.1"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Cancer"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1038\/nrc2044","type":"journal-article","created":{"date-parts":[[2006,11,24]],"date-time":"2006-11-24T16:17:57Z","timestamp":1164385077000},"page":"54-60","source":"Crossref","is-referenced-by-count":805,"title":["The Connectivity Map: a new tool for biomedical research"],"prefix":"10.1038","volume":"7","author":[{"given":"Justin","family":"Lamb","sequence":"first","affiliation":[]}],"member":"297","reference":[{"key":"BFnrc2044_CR1","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0049-3848(03)00379-7","volume":"110","author":"JR Vane","year":"2003","unstructured":"Vane, J. R. & Botting, R. M. The mechanism of action of aspirin. Thromb. Res. 110, 255\u2013258 (2003).","journal-title":"Thromb. Res."},{"key":"BFnrc2044_CR2","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1056\/NEJM200104053441401","volume":"344","author":"BJ Druker","year":"2001","unstructured":"Druker, B. J. et al. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N. Engl. J. Med. 344, 1031\u20131037 (2001).","journal-title":"N. Engl. J. Med."},{"key":"BFnrc2044_CR3","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1126\/science.2569237","volume":"245","author":"J Black","year":"1989","unstructured":"Black, J. Drugs from emasculated hormones: the principle of syntopic antagonism. Science 245, 486\u2013493 (1989).","journal-title":"Science"},{"key":"BFnrc2044_CR4","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1126\/science.1132939","volume":"313","author":"J Lamb","year":"2006","unstructured":"Lamb, J. et al. The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science 313, 1929\u20131935 (2006).","journal-title":"Science"},{"key":"BFnrc2044_CR5","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.ccr.2006.09.005","volume":"10","author":"H Hieronymus","year":"2006","unstructured":"Hieronymus, H. et al. Gene expression signature-based chemical genomic prediction identifies novel class of HSP90 pathway modulators. Cancer Cell 10, 321\u2013330 (2006).","journal-title":"Cancer Cell"},{"key":"BFnrc2044_CR6","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.ccr.2006.09.006","volume":"10","author":"G Wei","year":"2006","unstructured":"Wei, G. et al. Gene expression-based chemical genomics identifies rapamycin as a modulator of MCL-1 and glucocorticoid resistance. Cancer Cell 10, 331\u2013342 (2006).","journal-title":"Cancer Cell"},{"key":"BFnrc2044_CR7","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0092-8674(00)00015-5","volume":"102","author":"TR Hughes","year":"2000","unstructured":"Hughes, T. R. et al. Functional discovery via a compendium of expression profiles. Cell 102, 109\u2013126 (2000).","journal-title":"Cell"},{"key":"BFnrc2044_CR8","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/S1367-5931(03)00083-8","volume":"7","author":"CP Austin","year":"2003","unstructured":"Austin, C. P. The completed human genome: implications for chemical biology. Curr. Opin. Chem. Biol. 7, 511\u2013515 (2003).","journal-title":"Curr. Opin. Chem. Biol."},{"key":"BFnrc2044_CR9","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.mrfmmm.2003.12.019","volume":"549","author":"PD Cornwell","year":"2004","unstructured":"Cornwell, P. D., De Souza, A. T. & Ulrich, R. G. Profiling of hepatic gene expression in rats treated with fibric acid analogs. Mutat. Res. 549, 131\u2013145 (2004).","journal-title":"Mutat. Res."},{"key":"BFnrc2044_CR10","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1038\/nrd1202","volume":"2","author":"MA Lindsay","year":"2003","unstructured":"Lindsay, M. A. Target discovery. Nature Rev. Drug Discov. 2, 831\u2013838 (2003).","journal-title":"Nature Rev. Drug Discov."},{"key":"BFnrc2044_CR11","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/35094009","volume":"1","author":"BJ Feldman","year":"2001","unstructured":"Feldman, B. J. & Feldman, D. The development of androgen-independent prostate cancer. Nature Rev. Cancer 1, 34\u201345 (2001).","journal-title":"Nature Rev. Cancer"},{"key":"BFnrc2044_CR12","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/ng0506-500","volume":"38","author":"M Reich","year":"2006","unstructured":"Reich, M. et al. GenePattern 2.0. Nature Genet. 38, 500\u2013501 (2006).","journal-title":"Nature Genet."},{"key":"BFnrc2044_CR13","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1126\/science.1083395","volume":"300","author":"RL Strausberg","year":"2003","unstructured":"Strausberg, R. L. & Schreiber, S. L. From knowing to controlling: a path from genomics to drugs using small molecule probes. Science 300, 294\u2013295 (2003).","journal-title":"Science"},{"key":"BFnrc2044_CR14","doi-asserted-by":"publisher","first-page":"8935","DOI":"10.1158\/0008-5472.CAN-06-2552","volume":"66","author":"N Tolliday","year":"2006","unstructured":"Tolliday, N. et al. Small molecules, big players: the National Cancer Institute's initiative for chemical genetics. Cancer Res. 66, 8935\u20138942 (2006).","journal-title":"Cancer Res."},{"key":"BFnrc2044_CR15","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1056\/NEJMra023246","volume":"348","author":"IE Smith","year":"2003","unstructured":"Smith, I. E. & Dowsett, M. Aromatase inhibitors in breast cancer. N. Engl. J. Med. 348, 2431\u20132442 (2003).","journal-title":"N. Engl. J. Med."},{"key":"BFnrc2044_CR16","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s12031-002-0014-6","volume":"19","author":"JT Rogers","year":"2002","unstructured":"Rogers, J. T. et al. Alzheimer's disease drug discovery targeted to the APP mRNA 5\u2032untranslated region. J. Mol. Neurosci. 19, 77\u201382 (2002).","journal-title":"J. Mol. Neurosci."},{"key":"BFnrc2044_CR17","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1084\/jem.20032053","volume":"200","author":"IG Stavrovskaya","year":"2004","unstructured":"Stavrovskaya, I. G. et al. Clinically approved heterocyclics act on a mitochondrial target and reduce stroke-induced pathology. J. Exp. Med. 200, 211\u2013222 (2004).","journal-title":"J. Exp. Med."},{"key":"BFnrc2044_CR18","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/nature03180","volume":"433","author":"JD Rothstein","year":"2005","unstructured":"Rothstein, J. D. et al. \u03b2-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature 433, 73\u201377 (2005).","journal-title":"Nature"},{"key":"BFnrc2044_CR19","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1126\/science.1109027","volume":"307","author":"TM Miller","year":"2005","unstructured":"Miller, T. M. & Cleveland, D. W. Treating neurodegenerative diseases with antibiotics. Science 307, 361\u2013362 (2005).","journal-title":"Science"},{"key":"BFnrc2044_CR20","doi-asserted-by":"publisher","first-page":"7977","DOI":"10.1073\/pnas.1337088100","volume":"100","author":"AA Borisy","year":"2003","unstructured":"Borisy, A. A. et al. Systematic discovery of multicomponent therapeutics. Proc. Natl Acad. Sci. USA 100, 7977\u20137982 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrc2044_CR21","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/35078107","volume":"411","author":"SM Elbashir","year":"2001","unstructured":"Elbashir, S. M. et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411, 494\u2013498 (2001).","journal-title":"Nature"},{"key":"BFnrc2044_CR22","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/nrd892","volume":"1","author":"AL Hopkins","year":"2002","unstructured":"Hopkins, A. L. & Groom, C. R. The druggable genome. Nature Rev. Drug Discov. 1, 727\u2013730 (2002).","journal-title":"Nature Rev. Drug Discov."},{"key":"BFnrc2044_CR23","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1517\/14728222.8.6.587","volume":"8","author":"AP Orth","year":"2004","unstructured":"Orth, A. P., Batalov, S., Perrone, M. & Chanda, S. K. The promise of genomics to identify novel therapeutic targets. Expert Opin. Ther. Targets 8, 587\u2013596 (2004).","journal-title":"Expert Opin. Ther. Targets"},{"key":"BFnrc2044_CR24","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1038\/nature03193","volume":"432","author":"C Lipinski","year":"2004","unstructured":"Lipinski, C. & Hopkins, A. Navigating chemical space for biology and medicine. Nature 432, 855\u2013861 (2004).","journal-title":"Nature"},{"key":"BFnrc2044_CR25","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1038\/nbt1228","volume":"24","author":"GV Paolini","year":"2006","unstructured":"Paolini, G. V., Shapland, R. H., van Hoorn, W. P., Mason, J. S. & Hopkins, A. L. Global mapping of pharmacological space. Nature Biotechnol. 24, 805\u2013815 (2006).","journal-title":"Nature Biotechnol."},{"key":"BFnrc2044_CR26","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1101\/gr.2973604","volume":"14","author":"JF Rual","year":"2004","unstructured":"Rual, J. F. et al. Human ORFeome version 1. 1: a platform for reverse proteomics. Genome Res. 14, 2128\u20132135 (2004).","journal-title":"Genome Res."},{"key":"BFnrc2044_CR27","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/nmeth924","volume":"3","author":"DE Root","year":"2006","unstructured":"Root, D. E., Hacohen, N., Hahn, W. C., Lander, E. S. & Sabatini, D. M. Genome-scale loss-of-function screening with a lentiviral RNAi library. Nature Methods 3, 715\u2013719 (2006).","journal-title":"Nature Methods"},{"key":"BFnrc2044_CR28","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/nbt831","volume":"21","author":"AL Jackson","year":"2003","unstructured":"Jackson, A. L. et al. Expression profiling reveals off-target gene regulation by RNAi. Nature Biotechnol. 21, 635\u2013637 (2003).","journal-title":"Nature Biotechnol."},{"key":"BFnrc2044_CR29","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/ng1173","volume":"34","author":"AJ Bridge","year":"2003","unstructured":"Bridge, A. J., Pebernard, S., Ducraux, A., Nicoulaz, A. L. & Iggo, R. Induction of an interferon response by RNAi vectors in mammalian cells. Nature Genet. 34, 263\u2013264 (2003).","journal-title":"Nature Genet."},{"key":"BFnrc2044_CR30","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/ncb1038","volume":"5","author":"CA Sledz","year":"2003","unstructured":"Sledz, C. A., Holko, M., de Veer, M. J., Silverman, R. H. & Williams, B. R. Activation of the interferon system by short-interfering RNAs. Nature Cell Biol. 5, 834\u2013839 (2003).","journal-title":"Nature Cell Biol."},{"key":"BFnrc2044_CR31","doi-asserted-by":"publisher","first-page":"10315","DOI":"10.1073\/pnas.93.19.10315","volume":"93","author":"M Vidal","year":"1996","unstructured":"Vidal, M., Brachmann, R. K., Fattaey, A., Harlow, E. & Boeke, J. D. Reverse two-hybrid and one-hybrid systems to detect dissociation of protein-protein and DNA-protein interactions. Proc. Natl Acad. Sci. 93, 10315\u201310320 (1996).","journal-title":"Proc. Natl Acad. Sci."},{"key":"BFnrc2044_CR32","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/nmeth0605-412","volume":"2","author":"S Milstein","year":"2005","unstructured":"Milstein, S. & Vidal, M. Perturbing interactions. Nature Methods 2, 412\u2013414 (2005).","journal-title":"Nature Methods"},{"key":"BFnrc2044_CR33","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/nrd1346","volume":"3","author":"BL Roth","year":"2004","unstructured":"Roth, B. L., Sheffler, D. J. & Kroeze, W. K. Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia. Nature Rev. Drug Discov. 3, 353\u2013359 (2004).","journal-title":"Nature Rev. Drug Discov."},{"key":"BFnrc2044_CR34","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/nrd1609","volume":"4","author":"CT Keith","year":"2005","unstructured":"Keith, C. T., Borisy, A. A. & Stockwell, B. R. Multicomponent therapeutics for networked systems. Nature Rev. Drug Discov. 4, 71\u201378 (2005).","journal-title":"Nature Rev. Drug Discov."},{"key":"BFnrc2044_CR35","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1038\/437942a","volume":"437","author":"S Frantz","year":"2005","unstructured":"Frantz, S. Drug discovery: playing dirty. Nature 437, 942\u2013943 (2005).","journal-title":"Nature"},{"key":"BFnrc2044_CR36","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1038\/nature04209","volume":"437","author":"JF Rual","year":"2005","unstructured":"Rual, J. F. et al. Towards a proteome-scale map of the human protein-protein interaction network. Nature 437, 1173\u20131178 (2005).","journal-title":"Nature"},{"key":"BFnrc2044_CR37","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.sbi.2006.01.013","volume":"16","author":"AL Hopkins","year":"2006","unstructured":"Hopkins, A. L., Mason, J. S. & Overington, J. P. Can we rationally design promiscuous drugs? Curr. Opin. Struct. Biol. 16, 127\u2013136 (2006).","journal-title":"Curr. Opin. Struct. Biol."},{"key":"BFnrc2044_CR38","doi-asserted-by":"publisher","first-page":"15149","DOI":"10.1073\/pnas.211566398","volume":"98","author":"S Ramaswamy","year":"2001","unstructured":"Ramaswamy, S. et al. Multiclass cancer diagnosis using tumor gene expression signatures. Proc. Natl Acad. Sci. USA 98, 15149\u201315154 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrc2044_CR39","doi-asserted-by":"publisher","first-page":"4465","DOI":"10.1073\/pnas.012025199","volume":"99","author":"AI Su","year":"2002","unstructured":"Su, A. I. et al. Large-scale analysis of the human and mouse transcriptomes. Proc. Natl Acad. Sci. USA 99, 4465\u20134470 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrc2044_CR40","doi-asserted-by":"publisher","first-page":"6062","DOI":"10.1073\/pnas.0400782101","volume":"101","author":"AI Su","year":"2004","unstructured":"Su, A. I. et al. A gene atlas of the mouse and human protein-encoding transcriptomes. Proc. Natl Acad. Sci. USA 101, 6062\u20136067 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrc2044_CR41","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/nature01434","volume":"422","author":"EE Schadt","year":"2003","unstructured":"Schadt, E. E. et al. Genetics of gene expression surveyed in maize, mouse and man. Nature 422, 297\u2013302 (2003).","journal-title":"Nature"},{"key":"BFnrc2044_CR42","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1038\/ng1619","volume":"37","author":"M Mehrabian","year":"2005","unstructured":"Mehrabian, M. et al. Integrating genotypic and expression data in a segregating mouse population to identify 5-lipoxygenase as a susceptibility gene for obesity and bone traits. Nature Genet. 37, 1224\u20131233 (2005).","journal-title":"Nature Genet."},{"key":"BFnrc2044_CR43","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1038\/ng1589","volume":"37","author":"EE Schadt","year":"2005","unstructured":"Schadt, E. E. et al. An integrative genomics approach to infer causal associations between gene expression and disease. Nature Genet. 37, 710\u2013717 (2005).","journal-title":"Nature Genet."},{"key":"BFnrc2044_CR44","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.jbiotec.2005.03.022","volume":"119","author":"B Ganter","year":"2005","unstructured":"Ganter, B. et al. Development of a large-scale chemogenomics database to improve drug candidate selection and to understand mechanisms of chemical toxicity and action. J. Biotechnol. 119, 219\u2013244 (2005).","journal-title":"J. Biotechnol."},{"key":"BFnrc2044_CR45","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1093\/nar\/gkg091","volume":"31","author":"A Brazma","year":"2003","unstructured":"Brazma, A. et al. ArrayExpress-a public repository for microarray gene expression data at the EBI. Nucleic Acids Res. 31, 68\u201371 (2003).","journal-title":"Nucleic Acids Res."},{"key":"BFnrc2044_CR46","doi-asserted-by":"publisher","first-page":"D553","DOI":"10.1093\/nar\/gki056","volume":"33","author":"H Parkinson","year":"2005","unstructured":"Parkinson, H. et al. ArrayExpress-a public repository for microarray gene expression data at the EBI. Nucleic Acids Res. 33, D553\u2013D555 (2005).","journal-title":"Nucleic Acids Res."},{"key":"BFnrc2044_CR47","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1093\/nar\/30.1.207","volume":"30","author":"R Edgar","year":"2002","unstructured":"Edgar, R., Domrachev, M. & Lash, A. E. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 30, 207\u2013210 (2002).","journal-title":"Nucleic Acids Res."},{"key":"BFnrc2044_CR48","doi-asserted-by":"publisher","first-page":"D562","DOI":"10.1093\/nar\/gki022","volume":"33","author":"T Barrett","year":"2005","unstructured":"Barrett, T. et al. NCBI GEO: mining millions of expression profiles-database and tools. Nucleic Acids Res. 33, D562\u2013D566 (2005).","journal-title":"Nucleic Acids Res."},{"key":"BFnrc2044_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S1476-5586(04)80047-2","volume":"6","author":"DR Rhodes","year":"2004","unstructured":"Rhodes, D. R. et al. ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia 6, 1\u20136 (2004).","journal-title":"Neoplasia"},{"key":"BFnrc2044_CR50","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1126\/science.286.5439.531","volume":"286","author":"TR Golub","year":"1999","unstructured":"Golub, T. R. et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286, 531\u2013537 (1999).","journal-title":"Science"},{"key":"BFnrc2044_CR51","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/S0092-8674(03)00570-1","volume":"114","author":"J Lamb","year":"2003","unstructured":"Lamb, J. et al. A mechanism of cyclin D1 action encoded in the patterns of gene expression in human cancer. Cell 114, 323\u2013334 (2003).","journal-title":"Cell"},{"key":"BFnrc2044_CR52","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrc2044_CR53","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1101\/gr.2807605","volume":"15","author":"G Natsoulis","year":"2005","unstructured":"Natsoulis, G. et al. Classification of a large microarray data set: algorithm comparison and analysis of drug signatures. Genome Res. 15, 724\u2013736 (2005).","journal-title":"Genome Res."},{"key":"BFnrc2044_CR54","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/ng1305","volume":"36","author":"K Stegmaier","year":"2004","unstructured":"Stegmaier, K. et al. Gene expression-based high-throughput screening (GE-HTS) and application to leukemia differentiation. Nature Genet. 36, 257\u2013263 (2004).","journal-title":"Nature Genet."},{"key":"BFnrc2044_CR55","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1182\/blood-2005-02-0488","volume":"106","author":"K Stegmaier","year":"2005","unstructured":"Stegmaier, K. et al. Gefitinib induces myeloid differentiation of acute myeloid leukemia. Blood 106, 2841\u20132848 (2005).","journal-title":"Blood"},{"key":"BFnrc2044_CR56","doi-asserted-by":"publisher","first-page":"R61","DOI":"10.1186\/gb-2006-7-7-r61","volume":"7","author":"D Peck","year":"2006","unstructured":"Peck, D. et al. A method for high-throughput gene expression signature analysis. Genome Biol. 7, R61 (2006).","journal-title":"Genome Biol."},{"key":"BFnrc2044_CR57","first-page":"671","volume-title":"Goodman and Gilman's the pharmacological basis of therapeutics","author":"A Burke","year":"2006","unstructured":"Burke, A., Smyth, E. & FitzGerald, G. A. in Goodman and Gilman's the pharmacological basis of therapeutics (ed. Brunton, L. L.) 671\u2013715 (McGraw-Hill, New York, 2006)."},{"key":"BFnrc2044_CR58","doi-asserted-by":"publisher","first-page":"12953","DOI":"10.1074\/jbc.270.22.12953","volume":"270","author":"JM Lehmann","year":"1995","unstructured":"Lehmann, J. M. et al. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR\u03b3). J. Biol. Chem. 270, 12953\u201312956 (1995).","journal-title":"J. Biol. Chem."},{"key":"BFnrc2044_CR59","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/S0091-6749(96)70086-6","volume":"98","author":"TF Reiss","year":"1996","unstructured":"Reiss, T. F. et al. Effects of montelukast (MK-0476), a new potent cysteinyl leukotriene (LTD4) receptor antagonist, in patients with chronic asthma. J. Allergy Clin. Immunol. 98, 528\u2013534 (1996).","journal-title":"J. Allergy Clin. Immunol."},{"key":"BFnrc2044_CR60","first-page":"47","volume":"8","author":"M Boolell","year":"1996","unstructured":"Boolell, M. et al. Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. Int. J. Impot. Res. 8, 47\u201352 (1996).","journal-title":"Int. J. Impot. Res."},{"key":"BFnrc2044_CR61","doi-asserted-by":"publisher","first-page":"4342","DOI":"10.1200\/JCO.2003.04.190","volume":"21","author":"MC Heinrich","year":"2003","unstructured":"Heinrich, M. C. et al. Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor. J. Clin. Oncol. 21, 4342\u20134349 (2003).","journal-title":"J. Clin. Oncol."},{"key":"BFnrc2044_CR62","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0039-6257(99)00079-X","volume":"44","author":"MF Marmor","year":"1999","unstructured":"Marmor, M. F. & Kessler, R. Sildenafil (Viagra) and ophthalmology. Surv. Opthamol. 44, 153\u2013162 (1999).","journal-title":"Surv. Opthamol."},{"key":"BFnrc2044_CR63","doi-asserted-by":"publisher","first-page":"3406","DOI":"10.1074\/jbc.272.6.3406","volume":"272","author":"JM Lehmann","year":"1997","unstructured":"Lehmann, J. M., Lenhard, J. M., Oliver, B. B., Ringold, G. M. & Kliewer, S. A. Peroxisome proliferator-activated receptors \u03b1 and \u03b3 are activated by indomethacin and other non-steroidal anti-inflammatory drugs. J. Biol. Chem. 272, 3406\u20133410 (1997).","journal-title":"J. Biol. Chem."}],"container-title":["Nature Reviews Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrc2044.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrc2044","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrc2044.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T03:21:33Z","timestamp":1684466493000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrc2044"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["BFnrc2044"],"URL":"https:\/\/doi.org\/10.1038\/nrc2044","relation":{},"ISSN":["1474-175X","1474-1768"],"issn-type":[{"value":"1474-175X","type":"print"},{"value":"1474-1768","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}